Last updated on May 2019

Evaluation of TTP399 in Patients With Type 1 Diabetes


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of TTP399 in Type 1 diabetics. This study will be in 2 phases: phase 1 will evaluate the safety of different TTP399 dosage regimens over 1 week of daily dosing. Phase 2 will evaluate the safety and efficacy of a TTP399 dosing regimen over 12 weeks of daily dosing.

Clinical Study Identifier: NCT03335371

Find a site near you

Start Over

Site 04

Morehead City, NC United States
  Connect »

Diabetes & Endocrinology Consultants

Morehead City, NC United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.